Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control

References

• R.P. Araujo and D.L.S. McElwain, A history of the study of solid tumour growth: The contribution of mathematical modelling, Bull. Math. Biol. 66 (2004), pp. 1039–1091. doi: 10.1016/j.bulm.2003.11.002
   Google Scholar
• C. Baker and F. Rihan, Sensitivity analysis of parameters in modelling with delay-differential equations, MCCM Tec. Rep., 349, Manchester, ISSN: 1360–1725, 1999.
   Google Scholar
• N. Bellomo, N. Li, and P. Maini, On the foundations of cancer modeling: Selected topics, speculations, and perspectives, Math. Models. Methods Appl. Sci. 18 (2008), pp. 593–646. doi: 10.1142/S0218202508002796
   Google Scholar
• N. Bellomo and L. Preziosi, Modelling and mathematical problems related to tumour evolution and its reactions with immune system, Math. Comput. Model. 32 (2000), pp. 413–452. doi: 10.1016/S0895-7177(00)00143-6
   Google Scholar
• P. Calabresi and P.S. Schein, Medical Oncology: Basic Principles and Clinical Management of Cancer, 2nd ed., McGraw-Hill, New York, 1993.
   Google Scholar
• F. Castiglione and B. Piccoli, Cancer immunotherapy, mathematical modeling and optimal control, J. Theo. Biol. 247 (2007), pp. 723–732. doi: 10.1016/j.jtbi.2007.04.003
   Google Scholar
• M. Chaplain, Modelling aspects of cancer growth: Insights from mathematical and numerical analysis and computational simulation, in: Lecture Notes in Mathematics, Multiscale Problems in the Life Sciences Springer Vol. 1940, 2008, 147–200.
   Google Scholar
• K. Densise and T. Alexei, On the global dynamics of a model for tumour immunotherapy, J. Math. Biosci. Eng. 6(3) (2009), pp. 573–583. doi: 10.3934/mbe.2009.6.573
   Google Scholar
• A. Diefenbach, E.R. Jensen, A.M. Jamieson, and D. Raulet, Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity, Nature 413 (2001), pp. 165–171. doi: 10.1038/35093109
   Google Scholar
• M.E. Dudley, J.R. Wunderlich, P.F. Robbins, J.C. Yang, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, M.R. Robinson, M. Raffeld, p. Duray, C.A. Seipp, L. Rogers-Freezer, K.E. Morton, S.A. Mavroukakis, D.E. White, and S.A. Rosenberg, Cancer regression and autoimmunity in patients after clonal repopulation with antitumour lymphocytes, Science 298(5594) (2002), pp. 850–854. doi: 10.1126/science.1076514
   Google Scholar
• W.H. Fleming and R.W. Rishel, Deterministic and Stochastic Optimal Control, Springer, New York, NY, 1975.
   Google Scholar
• L. Göllmann, D. Kern, and H. Maurer, Optimal control problems with delays in state and control variables subject to mixed control-state constraints, Opt. Cont. Appl. Meth. 30(4) (2009), pp. 341–365. doi: 10.1002/oca.843
   Google Scholar
• A. Halany, Differential Equations: Stability, Oscillations, Time Lags, Academic Press, New York, NY, 1966.
   Google Scholar
• P. Kim, P. Lee, and D. Levy, Emergent group dynamics governed by regulatory cells produce a robust primary t cell response, Bull. Math. Biol. 72 (2010), pp. 611–644. doi: 10.1007/s11538-009-9463-1
   Google Scholar
• D. Krischner and J. Panetta, Modelling immunotherapy of the tumour-immune system interaction, J. Math. Biol. 37 (1998), pp. 235–252. doi: 10.1007/s002850050127
   Google Scholar
• P. Krishnapriya and M. Pitchaimani, Optimal control of mixed immunotherapy and chemotherapy of tumours with discrete delay, Int. J. Dyn. Control 5 (2015), pp. 872–892. doi: 10.1007/s40435-015-0221-y
   Google Scholar
• P. Krishnapriya and M. Pitchaimani, Modeling and bifurcation analysis of a viral infection with time delay and immune impairment, Jpn. J. Ind. Appl. Math. 34 (2017), pp. 99–139. doi: 10.1007/s13160-017-0240-5
   Google Scholar
• P. Krishnapriya and M. Pitchaimani, Analysis of time delay in viral infection model with immune impairment, J. Appl. Math. Comput. 55 (2017), pp. 421–453. doi: 10.1007/s12190-016-1044-5
   Google Scholar
• P. Krishnapriya, M. Pitchaimani, and T.M. Witten, Mathematical analysis of an Influenza A epidemic model with discrete delay, J. Comput. Appl. Math. 324 (2017), pp. 155–172. doi: 10.1016/j.cam.2017.04.030
   Google Scholar
• D.L. Lukes, Differential Equations: Classical to Controlled, Academic Press, New York NY, 1982.
   Google Scholar
• M.C. Maheswari, P. Krishnapriya, K. Krishnan, and M. Pitchaimani, A mathematical model of HIV-1 infection within host cell to cell viral transmissions with RTI and discrete delays, doi: https://doi.org/10.1007/s12190-016-1066-z, (2016).
   Google Scholar
• M.L. Martins, S.C. Ferreira Jr, and M.J. Vilela, Multiscale models for the growth of a vascular tumours, Phys. Life. Rev. 4 (2007), pp. 128–156. doi: 10.1016/j.plrev.2007.04.002
   Google Scholar
• J. Nagy, The ecology and evolutionary biology of cancer: A review of mathematical models of necrosis and tumour cells diversity, Math. Biosci. Eng. 2 (2005), pp. 381–418. doi: 10.3934/mbe.2005.2.381
   Google Scholar
• S. Rosenberg, Immunotherapy and gene therapy of cancer, Cancer Res. 51 (1991), pp. 5074s–5079s.
   Google Scholar
• S. Rosenberg, J. Yang, and N. Restifo, Cancer immunotherapy: Moving beyond current vaccines, Nat. Med. 10 (2004), pp. 909–915. doi: 10.1038/nm1100
   Google Scholar
• W. Shelby and L. Doron, A mathematical model of the enhancement of tumour vaccine efficacy by immunotherapy, Bull. Math. Biol. 74 (2012), pp. 1485–1500. doi: 10.1007/s11538-012-9722-4
   Google Scholar
• H. Siu, E.S. Vitetta, R.D. May, and I.W. Uhr, Tumour dormancy. I. Regression of BCL1 tumour and induction of a dormant tumour state in mica chimeric at the major histocompatibility complex, J. Immunol. 137 (1986), pp. 1376–1382.
   Google Scholar
• M. Terabe, E. Ambrosino, S. Takaku, J.J. O'Konek, D. Venzon, S. Lonning, J.P. McPherson, and J.A. Berzofsky, Synergistic enhancement of CD8+T cell-mediated tumour vaccine efficacy by an anti-transforming growth factor-β monoclonal antibody, Clin. Cancer Res. 15(21) (2009), pp. 6560–6569. doi: 10.1158/1078-0432.CCR-09-1066
   Google Scholar
• R. Yafia, Hopf bifurcation analysis and numerical simulations in an ODE model of the immune system with positive immune response, Nonlin. Anal: Real World. Appl. 8 (2007), pp. 1359–1369. doi: 10.1016/j.nonrwa.2006.08.003
   Google Scholar